Scholarlink

Background <p>Elevated serum concentrations of fibroblast growth factor 23 (FGF-23) are commonly observed in patients with chronic kidney disease on dialysis and appear to be associated with leptin levels and adipose tissue in this population. Therefore, this study aims to explore the association of FGF-23 with body adiposity and leptin in patients undergoing peritoneal dialysis.</p> Methods <p>This cross-sectional study included adult patients on peritoneal dialysis for at least 3 months. Adiposity was assessed by waist circumference and dual-energy X-ray absorptiometry. The adiposity parameters considered were total fat mass, trunk fat mass, body fat percentage, and waist circumference.</p> Results <p>A total of 50 patients on peritoneal dialysis were included, mean age 55.7 ± 16.2&#xa0;years, 52% female. A correlation was observed between FGF-23 and trunk fat mass (<i>r</i> = −0.293; <i>p</i> = 0.043). No significant correlation was found between FGF-23 and the other adiposity parameters. In multiple linear regression models adjusted for sex, FGF-23 was not significantly associated with adiposity parameters. However, after adjustment for leptin concentrations, FGF-23 showed an inverse association with total body fat (<i>β</i> = −0.341; <i>p</i> = 0.033) and waist circumference (<i>β</i> = −0.355; <i>p</i> = 0.042).</p> Conclusions <p>An inverse association between FGF-23 and body adiposity parameters was observed in patients on peritoneal dialysis after adjustment for leptin concentrations. Further studies are needed to clarify the mechanisms of this association.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Association between body adiposity and fibroblast growth factor 23 (FGF-23) in patients on peritoneal dialysis: an exploratory analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月16日

查看全文
  • Lorraine Faria Crozara Sousa,
  • Maryanne Zilli Canedo Silva,
  • Jacqueline Costa Teixeira Caramori,
  • Barbara Perez Vogt

摘要

Background

Elevated serum concentrations of fibroblast growth factor 23 (FGF-23) are commonly observed in patients with chronic kidney disease on dialysis and appear to be associated with leptin levels and adipose tissue in this population. Therefore, this study aims to explore the association of FGF-23 with body adiposity and leptin in patients undergoing peritoneal dialysis.

Methods

This cross-sectional study included adult patients on peritoneal dialysis for at least 3 months. Adiposity was assessed by waist circumference and dual-energy X-ray absorptiometry. The adiposity parameters considered were total fat mass, trunk fat mass, body fat percentage, and waist circumference.

Results

A total of 50 patients on peritoneal dialysis were included, mean age 55.7 ± 16.2 years, 52% female. A correlation was observed between FGF-23 and trunk fat mass (r = −0.293; p = 0.043). No significant correlation was found between FGF-23 and the other adiposity parameters. In multiple linear regression models adjusted for sex, FGF-23 was not significantly associated with adiposity parameters. However, after adjustment for leptin concentrations, FGF-23 showed an inverse association with total body fat (β = −0.341; p = 0.033) and waist circumference (β = −0.355; p = 0.042).

Conclusions

An inverse association between FGF-23 and body adiposity parameters was observed in patients on peritoneal dialysis after adjustment for leptin concentrations. Further studies are needed to clarify the mechanisms of this association.